Diagnosis of Prostate Cancer
The diagnosis of prostate cancer usually begins in your doctor’s office during a routine rectal exam followed by a blood test to measure prostate specific antigen (PSA). If your rectal exam shows abnormal changes or your PSA test is elevated, your doctor will need to do further testing to determine if you have cancer, benign prostatic hypertrophy , an infection, or some other condition.
|Anatomy of the Prostate Gland|
|Copyright © Nucleus Medical Media, Inc.|
- Blood tests—Your doctor will take a blood sample to test for prostatic specific antigen (PSA) . This is a chemical that indicates abnormalities in the prostate.
- Transrectal ultrasonography (or ultrasound)—An ultrasound probe is placed into the rectum as close to the prostate as possible. The probe releases painless sound waves that bounce off the inner tissues of the prostate. The echoes produced by the sound waves create a picture on a computer screen that helps distinguish normal prostate tissue from cancerous tissue.
- Transrectal biopsy —The biopsy sample is obtained by inserting a needle through the wall of the rectum into the prostate gland. Transrectal ultrasound is used to guide the doctor in placing the needle into the prostate. The area of the biopsy is usually numbed. This procedure typically takes 10-20 minutes and is performed in the doctor’s office.
StagingIf cancer is found in the biopsy sample, prognosis and treatment will primarily depend on:
- Stage of the cancer
- PSA value
- Your general health
- Gleason score—a measure of the aggressiveness of the cancer as seen under the microscope
- TNM staging system:
- Tumor size and local spread (T)
- Spread to lymph nodes in the area (N)
- Spread or metastasis to distant organs (M)
- Urine and blood tests
- Additional physical exam
- X-ray —A test that uses radiation to take a picture of structures inside the body, including lungs, bladder, kidney, and lymph nodes.
- Bone scan —A nuclear medicine scan that uses radioactive material injected into your body to detect abnormal areas of bone. This is usually not done unless your PSA is above 10 ng/mL or you have bone pain.
- CT or CAT scan —A type of x-ray that uses a computer to make pictures of structures inside the body.
- ProstaScint scan —A nuclear medicine scan that uses radioactive material injected into your body to detect prostate cells that may have traveled outside of the prostate. This study is still investigational and has not yet been proven to change disease management .
- MRI scan —A test that uses magnetic waves to make pictures of structures inside the body.
- Lymph node biopsy —Tissue samples are taken from the lymph nodes surrounding the prostate and sent to the laboratory for examination.
- Tumor size and local spread (T):
- T0: There is no evidence of tumor.
- T1: The cancer is not felt during a rectal exam nor seen by ultrasound. It is usually found during treatment for benign prostatic hypertrophy or during evaluation of an elevated PSA test.
- T2: The cancer can be felt during rectal exam, but is confined to the prostate.
- T3: The cancer has spread just outside the prostate and may involve the seminal vesicles.
- T4: The cancer has spread to local tissues beyond the prostate and seminal vesicles, organs, or lymph nodes.
- Spread to lymph nodes (N):
- N0: There is no evidence of cancer in any lymph node.
- N1: Cancer has spread to one nearby lymph node that is < 2 cm in size.
- N2: Cancer has spread to one nearby lymph node 2-5 cm in size or multiple lymph nodes all < 5 cm in size.
- N3: Cancer has spread to any nearby lymph nodes > 5 cm in size.
- Spread to distant organs (M):
- M0: There is no evidence of distant spread.
- M1: There is no distant spread to far removed lymph nodes, bones, or other organs.
Detailed guide: prostate cancer. American Cancer Societywebsite. Available at: http://www.cancer.org. Accessed October 9, 2008.
Prostate cancer. National Cancer Institutewebsite. Available at: http://www.cancer.gov/cancertopics/types/prostate. Accessed October 9, 2008.
- Reviewer: Mohei Abouzied, MD, FACP
- Review Date: 09/2014
- Update Date: 09/17/2014
Many medical groups felt that early exposure to certain foods like peanuts increased a child's risk of developing food allergies. However, newer research including this trial suggest that early exposure may actually decrease the risk of developing food allergies.
Breastfeeding May Decrease the Risk of Childhood Obesity
Tonsillectomy May Reduce Number of Sore Throat Days in Children
Research Review Finds Little Support for Nearly Half of Medical Talk Show Recommendations